Percolation thresholds of electrical conductivity in volume fraction (and in phr) for different carbon fillers were for CCB ∼0.14 (30 phr), for SCF ∼0.07 (15 phr) and for MWCNT mixed with solution process ∼0.03 (5 phr).
RESULTS: Calcium channel blocker (CCB) use and loop diuretic doses were higher in patients on the day before WRF (25% vs 10% for CCB; 199 +/- 195 mg vs 143 +/- 119 mg for loop diuretics; both P <.05).
Bank of China [3988.HK] posted a 29% increase in net earnings over 2009, China Construction Bank (CCB) [939 HK] saw a 26% boost, ICBC's [1398 HK] profits came in 28% higher, while the newly-listed Agricultural Bank of China (AgBank) [1288 HK] reported an eye-catching 46% rise in profits.
CCB, 1,3-diphenylpropane, and 2,4-diphenyl-1-butene also exhibited estrogenic activity after metabolic activation by liver microsomes, but the activity was lower than that of TCB.
Trans-1,2-diphenylcyclobutane (TCB), cis-1,2-diphenylcyclobutane (CCB), 1,3-diphenylpropane, 2,4-diphenyl-1-butene, 2,4,6-triphenyl-1-hexene, and 1-alpha-phenyl-4ss(1 -phenylethyl tetralin were negative in the yeast estrogen screening assay and estrogen reporter assay using estrogen-responsive human breast cancer cell line MCF-7.
Higher platelet counts (p<0.001), and co-medication with PPI (p<0.001) and CCB (p=0.03), were also significantly associated with individualisation of DAPT.
Are fibroblasts activated in CCB-treated animals in a manner similar to gingival overgrowth caused by CCB? 2) What is hydralazine's mechanism of action on VSMC? 3) There are no latex-injected images of hydralazine-treated aortas.
Of the 41 286 (58.2 %) patients on anti-hypertensive agents, angiotensin-converting enzyme inhibitors (ACEI) (63.9 %) were the most prescribed, followed by calcium channel blockers (CCB) (37 %) beta-blockers (36.5 %) and diuretics (23.4 %).
Four variables were independent risk factors of severe hyperkalemia (simplified scores in parentheses): medication of calcium channel blocker (CCB: 2); maximal precordial T ≥8.5 mV (2); PR (atrial fibrillation or junctional bradycardia: 1); and HR ≤40/minute (1).
Antihypertensive medication at baseline (number of patients in BEC versus PBO) was calcium channel blockers (CCB; 14 versus 12), α-1 blocker (prazosin; 3 versus 1), furosemide (13 versus 10), thiazides (1 versus 0), and spironolactone (0 versus 1).
Patients received monotherapy with an ACEI (27%), or CCB (22%), BB (20%), or diuretic (11%) and were classified as having high (80 100%), medium (50 79%), or low (<50%) medication compliance.
